Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2007 1
2008 1
2010 1
2011 4
2012 3
2013 3
2014 6
2015 6
2016 4
2017 2
2018 4
2019 5
2020 6
2021 3
2022 7
2023 5
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

51 results

Results by year

Filters applied: . Clear all
Page 1
Inflammation-related proteins as biomarkers of treatment-related behavioral symptoms: A longitudinal study of breast cancer patients and age-matched controls.
Patel SK, Breen EC, Paz IB, Kruper L, Mortimer J, Wong FL, Bhatia S, Irwin MR, Behrendt CE. Patel SK, et al. Among authors: kruper l. Brain Behav Immun Health. 2023 Jul 31;32:100670. doi: 10.1016/j.bbih.2023.100670. eCollection 2023 Oct. Brain Behav Immun Health. 2023. PMID: 37637432 Free PMC article.
Predicting All-Cause Mortality in Women With and Without Breast Cancer Using the Schonberg Index: A Women's Health Initiative Study.
Nelson RA, Soto-Perez-de-Celis E, Chlebowski RT, Schonberg M, Mortimer J, Pan K, Hou L, Neuhouser ML, Reding KW, Saquib N, Wactawski-Wende J, Wolfson E, Sedrak MS, Kruper L. Nelson RA, et al. Among authors: kruper l. J Natl Compr Canc Netw. 2023 Jun;21(6):636-644.e13. doi: 10.6004/jnccn.2023.7015. J Natl Compr Canc Netw. 2023. PMID: 37308127
Phase 2 prospective open label study of neoadjuvant nab-paclitaxel, trastuzumab, and pertuzumab in patients with HER2-positive primary breast cancer.
Lavasani SM, Somlo G, Yost SE, Frankel PH, Ruel C, Cui Y, Murga M, Tang A, Martinez N, Kruper L, Tumyan L, Schmolze D, Yeon C, Yuan Y, Waisman JR, Mortimer J. Lavasani SM, et al. Among authors: kruper l. Cancer. 2023 Mar 1;129(5):740-749. doi: 10.1002/cncr.34589. Epub 2022 Dec 14. Cancer. 2023. PMID: 36517940 Free PMC article. Clinical Trial.
Tumor-infiltrating exhausted CD8+ T cells dictate reduced survival in premenopausal estrogen receptor-positive breast cancer.
Egelston CA, Guo W, Tan J, Avalos C, Simons DL, Lim MH, Huang YJ, Nelson MS, Chowdhury A, Schmolze DB, Yim JH, Kruper L, Melstrom L, Margolin K, Mortimer JE, Yuan Y, Waisman JR, Lee PP. Egelston CA, et al. Among authors: kruper l. JCI Insight. 2022 Feb 8;7(3):e153963. doi: 10.1172/jci.insight.153963. JCI Insight. 2022. PMID: 35132960 Free PMC article.
51 results